Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-20

Clinical Trial Update: Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx [Phase 3]

View source ↗

Summary

Phase 3 trial assessing virucidal effect of povidone-iodine (PVP-I) on COVID-19 and safety of its application on nasopharynx and oropharynx; study status comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Povidone-iodine (povidone-iodine)

Snippet

Sponsor: DR. MALA KHAN | Conditions: Virus Infection, RNA, Effect of Drug | Phase 3 | Status: COMPLETED